Cargando…

Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis

BACKGROUND AND AIMS: Obesity is frequently associated with cirrhosis, and cirrhotic patients may develop simultaneous loss of skeletal muscle and gain of adipose tissue, culminating in the condition of sarcopenic obesity. Additionally, muscle depletion is characterized by both a reduction in muscle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montano‐Loza, Aldo J., Angulo, Paul, Meza‐Junco, Judith, Prado, Carla M. M., Sawyer, Michael B., Beaumont, Crystal, Esfandiari, Nina, Ma, Mang, Baracos, Vickie E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864157/ https://www.ncbi.nlm.nih.gov/pubmed/27493866 http://dx.doi.org/10.1002/jcsm.12039

Ejemplares similares

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
por: Montano-Loza, Aldo J, et al.
Publicado: (2015)

Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2022)

Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions
por: Ebadi, Maryam, et al.
Publicado: (2022)

Higher subcutaneous adipose tissue radiodensity is associated with increased mortality in patients with cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2022)

Concurrent depletion of skeletal muscle, fat, and left ventricular mass in patients with cirrhosis of the liver
por: Kazemi‐Bajestani, Seyyed Mohammad Reza, et al.
Publicado: (2015)

Sarcopenia Severity Based on Computed Tomography Image Analysis in Patients with Cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2020)

Visceral Adipose Tissue Radiodensity Is Linked to Prognosis in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy
por: Ebadi, Maryam, et al.
Publicado: (2020)

Fish oil mitigates myosteatosis and improves chemotherapy efficacy in a preclinical model of colon cancer
por: Almasud, Alaa A., et al.
Publicado: (2017)

Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
por: Stretch, Cynthia, et al.
Publicado: (2018)

Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis
por: Feng, Hongjuan, et al.
Publicado: (2021)

Association of myosteatosis with various body composition abnormalities and longer length of hospitalization in patients with decompensated cirrhosis
por: Wang, Xiaoyu, et al.
Publicado: (2022)

Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2018)

Is there a Role for Cyclophilin Inhibitors in the Management of Primary Biliary Cirrhosis?
por: Wasilenko, Shawn T., et al.
Publicado: (2013)

Sarcopenia in cirrhosis: from pathogenesis to interventions
por: Ebadi, Maryam, et al.
Publicado: (2019)

Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Metastatic gastric cancer – focus on targeted therapies
por: Meza-Junco, Judith, et al.
Publicado: (2012)

Computed Tomography-Derived Myosteatosis and Metabolic Disorders
por: Miljkovic, Iva, et al.
Publicado: (2021)

Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer
por: Okugawa, Yoshinaga, et al.
Publicado: (2022)

Critical appraisal of trastuzumab in treatment of advanced stomach cancer
por: Meza-Junco, Judith, et al.
Publicado: (2011)

The impact of sarcopenic obesity on knee and hip osteoarthritis: a scoping review
por: Godziuk, Kristine, et al.
Publicado: (2018)

High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
por: Fu, Chen, et al.
Publicado: (2023)

Learning from a rare phenomenon — spontaneous clearance of chronic hepatitis C virus post-liver transplant: A case report
por: Singh, Noreen, et al.
Publicado: (2022)

Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain)
por: Hernández-Martínez, Paula, et al.
Publicado: (2022)

Reliable Measures of Sarcopenia in Cirrhosis. Comment on: “The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097”
por: Ebadi, Maryam, et al.
Publicado: (2020)

The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis
por: Geladari, Eleni, et al.
Publicado: (2023)

Pelvic muscle size and myosteatosis: Relationship with age, gender, and obesity
por: Pacicco, Thomas, et al.
Publicado: (2019)

Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study
por: Chen, Xiaomei, et al.
Publicado: (2021)

Myosteatosis and nlr as predictors of poor outcomes in patients with Covid-19
por: Padilha, D.M.D.H., et al.
Publicado: (2021)

Impact of myopenia and myosteatosis on postoperative outcome and recurrence in Crohn’s disease
por: Pozios, Ioannis, et al.
Publicado: (2022)

Myosteatosis predicting risk of transition to severe COVID-19 infection
por: Yi, Xiaoping, et al.
Publicado: (2022)

Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
por: Kang, Min-Kyu, et al.
Publicado: (2022)

Effects of sarcopenia and myosteatosis are alleviated in reduced port surgery for diverticulitis
por: Schaffler-Schaden, Dagmar, et al.
Publicado: (2023)

Pitfalls in defining and quantifying cachexia
por: Baracos, Vickie E.
Publicado: (2011)

Psoas as a sentinel muscle for sarcopenia: a flawed premise
por: Baracos, Vickie E.
Publicado: (2017)

Sarcopenic obesity is associated with telomere shortening: findings from the NHANES 1999–2002
por: Goddard, Thomas, et al.
Publicado: (2021)

Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery
por: West, Malcolm A., et al.
Publicado: (2019)

The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease
por: O’Brien, Stephen, et al.
Publicado: (2018)

The Impact of Myosteatosis Percentage on Short-Term Mortality in Patients with Septic Shock
por: Kim, June-sung, et al.
Publicado: (2022)

Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tneh69ejjv686p32gqbkm4aa7l